159139-35-2

Basic information

• Product Name: Benzoic acid, 4-(1-methylethyl)-3-(methylsulfonyl)-
• Synonyms: 4-isopropyl-3-methanesulfonyl-benzoic acid;4-Isopropyl-3-methylsulfonylbenzoic acid
• CAS NO: 159139-35-2
• Molecular Formula: C11H14O4S
• Molecular Weight: 242.296
• Mol File: 159139-35-2.mol
• Article Data: 6

Chemical Properties

• Melting Point: 209 - 211 °C
• Boiling Point: 451.3±45.0 °C(Predicted)
• Density: 1.250±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzoic acid, 4-(1-methylethyl)-3-(methylsulfonyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(1-methylethyl)-3-(methylsulfonyl)-(159139-35-2)
• EPA Substance Registry System: Benzoic acid, 4-(1-methylethyl)-3-(methylsulfonyl)-(159139-35-2)

Safety Data

• Hazardous Substances Data: 159139-35-2(Hazardous Substances Data)

Upstream product

• 59815-29-1 3-(chlorosulfonyl)-4-isopropylbenzoic acid 
• 74-83-9 methyl bromide 
• 159139-34-1 2-Isopropyl-5-carboxybenzenesulfinic acid 
• 154117-61-0 methyl 3-methylsulfonyl-4-bromobenzoate 
• 176107-23-6 4-Isopropyl-3-methanesulfonyl-benzoic acid methyl ester 
• 536-66-3 p-isopropylbenzoic acid 
• 79-08-3 bromoacetic acid 

Downstream Products

• 167764-63-8 3-Methylsulfonyl-4-i-propylbenzoyl Chloride 
• 159138-80-4 cariporide 

Relevant articles and documents

COMPOUNDS FORTREATMENT OF CARDIOVASCULAR DISEASES

Pharmaceutical compositions containing sodium-hydrogen exchanger type 1 (NHE-1) inhibitors in combination with Ca 2+ overload inhibitors, and the use of such combination inhibitors to treat, for example, cardiovascular disease, such as ischemia, particularly, perioperative myocardial ischemic injury in mammals, including humans, are disclosed.

Substituted isoquinoline derivatives and their use as anticonvulsivants

This invention relates to novel substituted isoquinoline derivatives and their use as anticonvulsants.

Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith

Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them. The invention relates to benzoylguanidines of the formula I STR1 where R(1) or R(2) is R(3)-S(O)n -- or R(4)R(5)N--O2 S-- and